Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3038475 Target Snapshot

CDK9/Cyclin K · PROTEIN COMPLEX · Homo sapiens

188Compounds
60Assays
2Approved Drugs
123.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P50750. Use UniProt P50750 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P50750 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats CDK9/Cyclin K as ChEMBL target CHEMBL3038475, mapped to UniProt P50750. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
CDK9/Cyclin K
PROTEIN COMPLEX · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL3038475
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P50750
Cyclin-dependent kinase 9
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether CDK9/Cyclin K is the right protein anchor across sources, using UniProt P50750 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelCyclin-dependent kinase 9
UniProt AccessionP50750
Component TypeProtein
Sequence Length372 aa

Cyclin-dependent kinase 9

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as CDK9/Cyclin K, mapped to UniProt P50750. ChEMBL maps the protein component as Cyclin-dependent kinase 9. Sequence length is 372 aa.

Mapped IDP50750
Review nameCDK9/Cyclin K
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

2
Approved
3
Phase II
1
Phase I
Assay Mix

Activity Type Distribution

IC50121.0
KD2.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL3656841 8.7 IC50 2.0 Preclinical
CHEMBL4287416 8.7 IC50 2.0 Preclinical
CHEMBL4293213 8.7 IC50 2.0 Preclinical
CHEMBL5760232 8.7 IC50 2.0 Preclinical
CHEMBL5955040 8.7 IC50 2.0 Preclinical
CHEMBL1944698 8.52 IC50 3.0 Clinical
CHEMBL5961536 8.4 IC50 4.0 Preclinical
CHEMBL6043217 8.4 IC50 4.0 Preclinical
CHEMBL6058548 8.3 IC50 5.0 Preclinical
CHEMBL4281048 8.22 IC50 6.0 Preclinical
Distribution

pChEMBL Value Distribution

10
5.0
12
5.5
9
6.0
16
6.5
14
7.0
10
7.5
6
8.0
6
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

ABEMACICLIB
CHEMBL3301610
Approved 2017
Assay Landscape

Assay Landscape

60
Total Assays
79
Tested Compounds
1
Assay Types
Binding — 60 assays, 79 compounds
BAO Format Assays Compounds Avg pChEMBL
protein complex format 49 51 7.1
cell-based format 9 27 6.1
assay format 2 1 8.5

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine